Company Filing History:
Years Active: 2005-2023
Title: The Innovative Contributions of Alain Robert
Introduction
Alain Robert is a notable inventor based in Annemasse, France. He has made significant contributions to the field of cancer treatment through his innovative inventions. With a total of 6 patents, Robert's work focuses on antibody-drug conjugates and their applications in oncology.
Latest Patents
Among his latest patents, Robert has developed an IGF-1R antibody-drug-conjugate designed for the treatment of cancer. This invention involves an antibody capable of binding to IGF-1R, which is conjugated to drugs derived from dolastatin 10 and auristatins. Additionally, he has patented an IGF-1R antibody that serves as an addressing vehicle for cancer treatment. This monoclonal antibody can induce internalization of IGF-1R, allowing it to be used in conjunction with other anti-cancer compounds.
Career Highlights
Throughout his career, Alain Robert has worked with prominent companies in the pharmaceutical industry, including Pierre Fabre Medicament and Pierre Fabre Médicament. His expertise in developing innovative cancer therapies has positioned him as a key figure in the field.
Collaborations
Robert has collaborated with notable colleagues such as Liliane Goetsch and Matthieu Broussas, contributing to the advancement of cancer treatment methodologies.
Conclusion
Alain Robert's innovative work in the development of antibody-drug conjugates highlights his commitment to improving cancer therapies. His contributions continue to influence the field and offer hope for more effective treatments.